Senzime AB Total Assets

Latest as of June 2026: Skr325.40 Million SEK ≈ $35.02 Million USD

Senzime AB total assets. Based on the latest financial reports, Senzime AB (SEZI) holds total assets worth Skr325.40 Million SEK (≈ $35.02 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Senzime AB market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Senzime AB (2005–2025)

Total assets of Senzime AB from 2005 to 2025. This chart illustrates how Senzime AB's total assets have evolved over time, based on quarterly financial data. See SEZI share price today for real-time trading data and today's change.

Senzime AB - Asset Composition Analysis

Senzime AB Total Assets Breakdown (December 2025)

Senzime AB total assets breakdown as of December 2025. Senzime AB's total assets of Skr325.40 Million consist of 34.6% current assets and 65.4% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr73.97 Million	20.0%
Accounts Receivable	Skr21.43 Million	5.8%
Inventory	Skr25.17 Million	6.8%
Property, Plant & Equipment	Skr18.31 Million	5.0%
Intangible Assets	Skr122.95 Million	33.3%
Goodwill	Skr96.05 Million	26.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Senzime AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Senzime AB (SEZI) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Senzime AB's current assets represent 34.6% of total assets in 2025, an increase from 0.0% in 2005.
Cash Position: Cash and equivalents constituted 20.0% of total assets in 2025, up from 2.8% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, an increase from 10.0% in 2005.
Asset Diversification: The largest asset category is intangible assets at 33.3% of total assets.

Senzime AB Competitors by Total Assets

Key competitors of Senzime AB based on total assets are shown below.

Company	Country	Total Assets
HOB Biotech Group Corp Ltd SHG:688656	China	CN¥916.43 Million
L&C Bio Co. Ltd KQ:290650	Korea	₩497.94 Billion
Applied BioCode TW:6598	Taiwan	NT$1.03 Billion
Oncosil Medical Ltd AU:OSL	Australia	AU$7.13 Million
Sequana Medical NV BR:SEQUA	Belgium	€14.57 Million
Cleo Diagnostics Ltd AU:COV	Australia	AU$9.96 Million
Radiant Innovation TWO:3373	Taiwan	NT$859.52 Million
MedX Health Corp V:MDX	Canada	CA$1.26 Million

Senzime AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.31	6.22	13.87
Quick Ratio	2.42	5.17	12.84
Cash Ratio	0.00	4.46	11.70
Working Capital	Skr55.78 Million	Skr154.47 Million	Skr107.18 Million

Senzime AB - Advanced Valuation Insights

This section examines the relationship between Senzime AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.89
Latest Market Cap to Assets Ratio	0.15
Asset Growth Rate (YoY)	-13.3%
Total Assets	Skr369.81 Million
Market Capitalization	$54.99 Million USD

Valuation Analysis

Below Book Valuation: The market values Senzime AB's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Senzime AB's assets decreased by 13.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Senzime AB (2005–2025)

The table below shows the annual total assets of Senzime AB from 2005 to 2025.

Year	Total Assets	Change
2025-12-31	Skr369.81 Million ≈ $39.80 Million	-13.26%
2024-12-31	Skr426.36 Million ≈ $45.88 Million	-1.66%
2023-12-31	Skr433.54 Million ≈ $46.66 Million	+34.36%
2022-12-31	Skr322.68 Million ≈ $34.73 Million	+84.79%
2021-12-31	Skr174.62 Million ≈ $18.79 Million	-32.55%
2020-12-31	Skr258.89 Million ≈ $27.86 Million	+37.88%
2019-12-31	Skr187.76 Million ≈ $20.21 Million	-4.77%
2018-12-31	Skr197.16 Million ≈ $21.22 Million	+18.75%
2017-12-31	Skr166.03 Million ≈ $17.87 Million	+6.22%
2016-12-31	Skr156.31 Million ≈ $16.82 Million	+226.99%
2015-12-31	Skr47.80 Million ≈ $5.14 Million	+3.21%
2014-12-31	Skr46.32 Million ≈ $4.98 Million	+19.90%
2013-12-31	Skr38.63 Million ≈ $4.16 Million	+16.24%
2012-12-31	Skr33.23 Million ≈ $3.58 Million	+4.97%
2011-12-31	Skr31.66 Million ≈ $3.41 Million	+22.12%
2010-12-31	Skr25.92 Million ≈ $2.79 Million	+22.41%
2009-12-31	Skr21.18 Million ≈ $2.28 Million	-8.56%
2008-12-31	Skr23.16 Million ≈ $2.49 Million	+69.54%
2007-12-31	Skr13.66 Million ≈ $1.47 Million	+26.84%
2006-12-31	Skr10.77 Million ≈ $1.16 Million	+11.03%
2005-12-31	Skr9.70 Million ≈ $1.04 Million	--

About Senzime AB

ST:SEZI Sweden Medical Devices

Market Cap

$54.99 Million

Skr510.95 Million SEK

Market Cap Rank

#21351 Global

#390 in Sweden

Share Price

Skr3.25

Change (1 day)

+3.83%

52-Week Range

Skr2.42 - Skr5.81

All Time High

Skr26.50